§ 13F · FUND PROFILE
NEXTBio Capital Management LP.
AUM · $217M (13F)Positions · 22Turnover · n/a · Q2Filed · Aug 14, 2026
CONCENTRATION
n/a
Top 10 holdings
NEW BUYS
0
+$8M deployed
EXITS
0
No exits
SECTOR SHIFT
n/a
No prior quarter data
§ 01 · TOP HOLDINGS
The book · Q2 2026
FILED AUG 14, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | PTGX | PROTAGONIST THERAPEUTICS INC | 219K | $27M | 12.4% | −4% |
| 2 | STTK | SHATTUCK LABS INC | 3.73M | $26M | 11.9% | +18% |
| 3 | CMPS | COMPASS PATHWAYS PLC | 1.78M | $25M | 11.6% | −12% |
| 4 | GPCR | STRUCTURE THERAPEUTICS INC | 312K | $17M | 7.7% | +135% |
| 5 | VOR | VOR BIOPHARMA INC | 889K | $16M | 7.5% | −11% |
| 6 | RYTM | RHYTHM PHARMACEUTICALS INC | 132K | $15M | 6.7% | +5% |
| 7 | PVLA | PALVELLA THERAPEUTICS INC NE | 90K | $14M | 6.3% | +9% |
| 8 | XENE | XENON PHARMACEUTICALS INC | 183K | $11M | 5.1% | ±0% |
| 9 | ZBIO | ZENAS BIOPHARMA INC | 427K | $11M | 5.0% | ±0% |
| 10 | ORIC | ORIC PHARMACEUTICALS INC | 706K | $8M | 3.5% | +35% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE NEXTBIO SIGNAL
AC read
NEXTBio Capital Management LP is a Other fund managing $217 million in assets. The fund runs a focused portfolio of just 22 positions.
Read the full dossier →